Analyst Coverage Diverges Sharply on Health In Tech's Path to Profitability
Health In Tech, Inc. (NASDAQ: HIT) is drawing a split verdict from Wall Street, with fresh estimates from Maxim Group projecting continued losses through fiscal 2026 before a narrow path toward